Newsletter | March 7, 2026

03.07.26 -- Drug Discovery Online Best Of February

FEBRUARY'S BEST FEATURED EDITORIAL

CROs In Drug Discovery, Part 3: Budgets, Timelines, And Avoiding Pitfalls

Part 3 of this series covers managing budgets, timelines, and avoiding operational pitfalls.

Designing Drugs For Women: Closing The Therapeutic Gap

Women’s health remains underdeveloped in drug innovation. Growing momentum across policy, science, and funding creates an opportunity to better align drug discovery with women’s health needs.

Insights From The Non-Opioid Pain Therapeutics Summit: Human-Centric Translational Models And The Reawakening Of Pain Pipelines

The 2026 Inaugural Non-Opioid Pain Therapeutics Summit brought together a diverse group of scientists, clinicians, and drug hunters to discuss developing safe, effective pain medicines without the addictive properties associated with opioids.

FEBRUARY'S BEST INDUSTRY INSIGHTS

Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

Everything You Need To Know About NGS

Next generation sequencing technologies and workflow automation are accelerating genomic research. Learn key differences between sequencing methods and uncover strategies to boost efficiency.

The Most Exciting Frontiers In Cell Therapy Development

From high-dimensional profiling to customizable Omic panels, new technologies are redefining cell therapy development—delivering better insights, efficiency, and scalability for researchers worldwide.

FEBRUARY'S BEST SOLUTIONS

The Essential Role Of High-Quality Anti-Host Cell Protein Antibody Reagents

Reduce Drug Absorption With This Basic Research Kit

Your Molecule. Our Mission.